Heart failure
Heart failure is a condition in which the heart has lost the ability to pump enough blood to the body’s tissues. With too little blood being delivered, the organs and other tissues do not receive enough oxygen and nutrients to function properly.
COPD patients at higher risk of heart failure
COPD patients at significantly higher risk of heart failure – Patients with chronic obstructive pulmonary disease (COPD) have a complication to worry about is heart failure. A new study found the prevalence of heart failure is significantly higher in patients with COPD compared to the rest of the study population. They also found that the risk was especially high among African-American patients with COPD.
Diabetes duration and advancing age independently predict diabetes complications
Duration of diabetes and advancing age independently predict diabetes complications, risk of death – The duration of diabetes and advancing age independently predict diabetes severity and risk of death in older adults with type 2 diabetes. In a new study led by Kaiser Permanente and the University of Chicago, researchers investigated contemporary rates of diabetes complications and risk of death then contrasted them across categories of age and duration of diabetes.
Disrupting an antioxidant pathway prevents heart failure
Disrupting an antioxidant pathway prevents heart disease caused by reductive stress – Researchers have found that deficiency of an antioxidant response protein called nuclear erythroid-2 like factor-2 (Nrf2) delays or prevents hypertrophic cardiomyopathy, a type of a heart failure in which the heart muscle grows abnormally thick.
Nanodiamonds may improve effectiveness of breast cancer treatment
UCLA researchers find nanodiamonds could improve effectiveness of breast cancer treatment – Recently, doctors have begun to categorize breast cancers into four main groups according to the genetic makeup of the cancer cells. Which category a cancer falls into generally determines the best method of treatment.
Darbepoetin alfa does not improve health of anemic heart failure patients
Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients — Phase 3 findings published in NEJM provide answers about treatment with darbepoetin alfa – Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients – darbepoetin alfa – does not improve patients’ health, nor does it reduce their risk of death from heart failure.